Blogs about EYE - Stockpickr! Your Source for Stock Ideas

Blogs about EYE

Blogs	Description	Date Updated
Advanced Medical Optics (EYE): Shares cycle in bullish 'pennant'	Filed under: Earnings reports, Technical Analysis, Stocks to BuyAdvanced Medical Optics (NYSE: EYE) manufactures and sells a variety of medical devices used to correct vision problems. Its cataract/implant products include artificial lenses used to replace human lenses, plus instruments and systems employed during the implantation surgery. Its laser systems are used in a variety of FDA-approved vision correction procedures. Its eye care product line features contact lens care solutions. The com...	February 29, 2008
Monday's Upgrades and Downgrades	UPGRADESNorthrop Grumman (NOC)= Credit Suisse Neutral » Outperform Rackable Systems (RACK)= Canaccord Adams Sell » Hold Open Text (OTEX)= Canaccord Adams Hold » Buy Finlay Enterprises (FNLY)= B. Riley & Co Sell » Neutral USANA (USNA)= Wedbush Morgan Hold » Buy Performance Food (PFGC)= UBS Sell » Neutral Weatherford (WFT)= Wachovia Mkt Perform » Outperform Baker Hughes (BHI)= Wachovia Mkt Perform » Outperform ENGlobal (ENG)= SMH Capital Sell » Buy ...	January 13, 2008
Analyst upgrades: DELL, HPQ and EYE	Filed under: Analyst upgrades and downgrades, Dell (DELL), Hewlett-Packard (HPQ)MOST NOTEWORTHY: Dell, Hewlett-Packard and Advanced Medical were today's noteworthy upgrades: JP Morgan upgraded shares of Dell (NASDAQ:DELL) to Overweight from Neutral on valuation, as they believe current levels provide an attractive entry point. JP Morgan thinks their bearish view on 2008 growth and margins has been priced into shares. JP Morgan added Hewlett-Packard (NYSE:HPQ) to its U.S. Focus List,...	January 11, 2008
Advanced Medical (EYE) and Holder ValueAct Battle It Out on Bausch & Lomb (BOL) Bid	In an amended 13D filing after the close on Advanced Medical Optics (NYSE: EYE), the company's largest shareholder (14.7%), ValueAct Capital, disclosed a letter to the company opposing its bid for Bausch & Lomb Inc. (NYSE: BOL).From ValueAct's Letter: "We believe an AMO acquisition of B&L would impair our expected risk-adjusted return as AMO shareholders. The proposed acquisition increases business risk by further concentrating AMO cash flows in a consumer contact lens and lens care business tha...	July 11, 2007
Advanced Medical (EYE) and Holder ValueAct Battle It Out on Bausch & Lomb (BOL) Bid	In an amended 13D filing after the close on Advanced Medical Optics (NYSE: EYE), the company's largest shareholder (14.7%), ValueAct Capital, disclosed a letter to the company opposing its bid for Bausch & Lomb Inc. (NYSE: BOL).From ValueAct's Letter: "We believe an AMO acquisition of B&L would impair our expected risk-adjusted return as AMO shareholders. The proposed acquisition increases business risk by further concentrating AMO cash flows in a consumer contact lens and lens care business tha...	July 11, 2007
Pre-Market Analyst Calls (July 11, 2007)	ABT started as Outperform at Wachovia.ACL started as Outperform at Wachovia.AGN started as Outperform at Wachovia.ATVI cut to Neutral at JPMorgan.BAS cut to Sector Perform at RBC.BJS cut to Sector Perform at RBC.BOL started as Mkt Perform at Wachovia.BSX started as Mkt Perform at Wachovia.CME cut to Hold at Deutsche Bank.COO started as Mkt Perform at Wachovia.CPB raised to Overweight at JPMorgan.EFX raised to Outperform at JMP Securities.ESS raised to Overweight at Lehman.EW started as Outperfor...	July 11, 2007
SAC Capital / Steven A. Cohen Discloses 5.5% Stake in Bausch & Lomb (BOL) in 13D	In a 13D filing after the close on Bausch & Lomb Inc. (NYSE: BOL), SAC Capital / Steven A. Cohen disclosed a 5.5% stake (2,989,995 shares) in the company. The firm held 33,800 BOL shares at tHe quarter ended March 31, 2007.In a boilerplate disclosure, SAC said they intend to monitor the investment and may seek discussions with management or the board in the future.Late Thursday, Advanced Medical Optics (NYSE: EYE) announced a $75 per share offer for Bausch & Lomb, topping a $65 bid from priv...	July 06, 2007
SAC Capital / Steven A. Cohen Discloses 5.5% Stake in Bausch & Lomb (BOL) in 13D	In a 13D filing after the close on Bausch & Lomb Inc. (NYSE: BOL), SAC Capital / Steven A. Cohen disclosed a 5.5% stake (2,989,995 shares) in the company. The firm held 33,800 BOL shares at tHe quarter ended March 31, 2007.In a boilerplate disclosure, SAC said they intend to monitor the investment and may seek discussions with management or the board in the future.Late Thursday, Advanced Medical Optics (NYSE: EYE) announced a $75 per share offer for Bausch & Lomb, topping a $65 bid from priv...	July 06, 2007
Media Digest 7/6/2006 Reuters, WSJ, NYTimes, FT, Barron's	According to Reuters, Advanced Medical Optic (EYE) has made a $4.23 billion bid forBausch & Lomb (BOL). Reuters writes that UBS has replaced its CEO after loses at it hedge fund. The Wall Street Journal reports that Microsoft (MFST) will take a $1.1 billion charge for costs related to warranties for its Xbox. The Wall Street Journal writes that Congress is passing a bill the would allow OPEC members to be sued under antitrust laws. The Wall Street Journal also writes that...	July 06, 2007
Is $75.00 For Bausch & Lomb the FINAL Offer?	Bausch & Lomb (BOL-NYSE) has received a higher buyout price from Advanced Medical Optics (EYE-NYSE) (or 'AMO' hereafter) in a cash and stock merger where Bausch & Lomb's shareholders would receive $45.00 in cash and roughly $30.00 in AMO stock, valued based on the average closing price of the AMO common stock for five trading days prior to the date a definitive agreement is signed. The new proposal is subject to termination of Bausch & Lomb's previously announced merg...	July 05, 2007

Enter search text here: